Wilson TR - Search Results

1

Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLC.

Sisoudiya SD, Houle AA, Fernando T, Wilson TR, Schutzman JL, Lee J, Schrock A, Sokol ES, Sivakumar S, Shi Z, Pathria G. Sisoudiya SD, et al. Among authors: wilson tr. NPJ Precis Oncol. 2024 Jul 20;8(1):153. doi: 10.1038/s41698-024-00644-4. NPJ Precis Oncol. 2024. PMID: 39033203 Free PMC article.

2

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.

Westphalen CB, Krebs MG, Le Tourneau C, Sokol ES, Maund SL, Wilson TR, Jin DX, Newberg JY, Fabrizio D, Veronese L, Thomas M, de Braud F. Westphalen CB, et al. Among authors: wilson tr. NPJ Precis Oncol. 2021 Jul 20;5(1):69. doi: 10.1038/s41698-021-00206-y. NPJ Precis Oncol. 2021. PMID: 34285332 Free PMC article.

3

Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.

Westphalen CB, Krebs MG, Le Tourneau C, Sokol ES, Maund SL, Wilson TR, Jin DX, Newberg JY, Fabrizio D, Veronese L, Thomas M, de Braud F. Westphalen CB, et al. Among authors: wilson tr. NPJ Precis Oncol. 2021 Sep 17;5(1):86. doi: 10.1038/s41698-021-00222-y. NPJ Precis Oncol. 2021. PMID: 34535754 Free PMC article. No abstract available.

4

NTRK gene fusions are detected in both secretory and non-secretory breast cancers.

Maund SL, Sokol ES, Ang Houle A, Ross JS, Wilson TR. Maund SL, et al. Among authors: wilson tr. Pathol Int. 2022 Mar;72(3):187-192. doi: 10.1111/pin.13204. Epub 2022 Jan 31. Pathol Int. 2022. PMID: 35102630

5

Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations.

Sivakumar S, Jin DX, Rathod R, Ross J, Cantley LC, Scaltriti M, Chen JW, Hutchinson KE, Wilson TR, Sokol ES, Vasan N. Sivakumar S, et al. Among authors: wilson tr. Clin Cancer Res. 2023 Mar 14;29(6):1125-1136. doi: 10.1158/1078-0432.CCR-22-2270. Clin Cancer Res. 2023. PMID: 36595567 Free PMC article.

6

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancers.

Hutchinson KE, Chen JW, Savage HM, Stout TJ, Schimmoller F, Cortés J, Dent S, Harbeck N, Jacot W, Krop I, Trabucco SE, Sivakumar S, Sokol ES, Wilson TR. Hutchinson KE, et al. Among authors: wilson tr. Genome Med. 2023 Apr 26;15(1):28. doi: 10.1186/s13073-023-01181-8. Genome Med. 2023. PMID: 37101291 Free PMC article.

7

Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models.

Moore HM, Savage HM, O'Brien C, Zhou W, Sokol ES, Goldberg ME, Metcalfe C, Friedman LS, Lackner MR, Wilson TR. Moore HM, et al. Among authors: wilson tr. Mol Cancer Ther. 2020 Jan;19(1):292-303. doi: 10.1158/1535-7163.MCT-19-0284. Epub 2019 Sep 18. Mol Cancer Ther. 2020. PMID: 31534012

8

VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.

Lindeman GJ, Fernando TM, Bowen R, Jerzak KJ, Song X, Decker T, Boyle F, McCune S, Armstrong A, Shannon C, Bertelli G, Chang CW, Desai R, Gupta K, Wilson TR, Flechais A, Bardia A. Lindeman GJ, et al. Among authors: wilson tr. Clin Cancer Res. 2022 Aug 2;28(15):3256-3267. doi: 10.1158/1078-0432.CCR-21-3811. Clin Cancer Res. 2022. PMID: 35583555 Free PMC article. Clinical Trial.

9

The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population.

Wilson TR, Yu J, Lu X, Spoerke JM, Xiao Y, O'Brien C, Savage HM, Huw LY, Zou W, Koeppen H, Forrest WF, Fridlyand J, Fu L, Tam R, Schleifman EB, Sumiyoshi T, Molinero L, Hampton GM, O'Shaughnessy JA, Lackner MR. Wilson TR, et al. NPJ Breast Cancer. 2016 Jul 13;2:16022. doi: 10.1038/npjbcancer.2016.22. eCollection 2016. NPJ Breast Cancer. 2016. PMID: 28721382 Free PMC article.

10

ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes.

Chen JW, Jacot W, Cortés J, Krop IE, Dent S, Harbeck N, De Laurentiis M, Diéras V, Im YH, Stout TJ, Schimmoller F, Savage HM, Hutchinson KE, Wilson TR. Chen JW, et al. Among authors: wilson tr. Mol Oncol. 2023 Oct;17(10):2000-2016. doi: 10.1002/1878-0261.13416. Epub 2023 Mar 25. Mol Oncol. 2023. PMID: 36892268 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page